Exagen Inc.
XGN
$7.31
$0.010.14%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 20.83% | 20.55% | 19.65% | 14.08% | 3.89% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.83% | 20.55% | 19.65% | 14.08% | 3.89% |
| Cost of Revenue | 23.16% | 23.45% | 23.29% | 11.14% | 3.16% |
| Gross Profit | 19.23% | 18.56% | 17.18% | 16.14% | 4.39% |
| SG&A Expenses | 12.37% | 12.95% | 12.67% | 2.33% | -3.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.68% | 16.66% | 16.41% | 6.92% | 0.60% |
| Operating Income | 5.91% | -0.86% | -3.18% | 18.97% | 11.17% |
| Income Before Tax | -11.47% | -29.58% | -31.76% | -12.40% | 2.03% |
| Income Tax Expenses | 2.04% | 625.00% | 325.00% | 51.52% | 48.48% |
| Earnings from Continuing Operations | -11.44% | -30.04% | -31.99% | -12.48% | 1.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.44% | -30.04% | -31.99% | -12.48% | 1.93% |
| EBIT | 5.91% | -0.86% | -3.18% | 18.97% | 11.17% |
| EBITDA | 12.41% | 3.66% | -0.34% | 22.37% | 10.93% |
| EPS Basic | 9.70% | -4.62% | -10.83% | 1.34% | 7.93% |
| Normalized Basic EPS | 9.45% | 1.23% | -0.62% | 17.52% | 11.57% |
| EPS Diluted | 9.70% | -4.62% | -10.83% | 1.34% | 7.93% |
| Normalized Diluted EPS | 9.45% | 1.23% | -0.62% | 17.52% | 11.57% |
| Average Basic Shares Outstanding | 23.86% | 24.57% | 18.34% | 12.18% | 6.52% |
| Average Diluted Shares Outstanding | 23.86% | 24.57% | 18.34% | 12.18% | 6.52% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |